Targeting the Metabotropic Glutamate Receptor mGluR4 for the Treatment of Diseases of the Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|5|9|885-895

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.5, Iss.9, 2005-08, pp. : 885-895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

By Célanire Sylvain   Campo Brice  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 3, 2012-03 ,pp. : 261-280

Informa Healthcare

Access to resources Recommend Favorite

Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-01 ,pp. : 738-744

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors in Central Nervous System Diseases

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 538-616

Bentham Science Publishers

Access to resources Recommend Favorite

In Vivo Imaging of the Metabotropic Glutamate Receptor 1 (mGluR1) with Positron Emission Tomography: Recent Advance and Perspective

By  

Current Medicinal Chemistry, Vol. 21, Iss. 1, 2014-01 ,pp. : 113-123

Bentham Science Publishers

Access to resources Recommend Favorite

Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 558-566

Bentham Science Publishers

Access to resources Recommend Favorite